Partner Content Partner Content Understanding Adherence: 5 Questions Patients Want to Be Ask... Various factors impact treatment plan adherence
Partner Content Partner Content Health Union Acquires WEGO Health Combination establishes leading force in social health
Partner Content Partner Content COUCH Health Engages Mark Duman as Chief Strategy Officer COUCH Health, a patient engagement agency, announced the appointment of Mark Duman as its Chief Strategy Officer (CSO).
Partner Content Partner Content COUCH Health Finds Reasons Behind Underrepresentation of Min... New research shows how to improve trial diversity
Views & Analysis Why relationships are key in rare disease patient engagement Real-world data is a vital part of rare disease drug development, but to get a true picture of patients’ unmet needs pharma should take a broader view of their lived experiences, says Xperi
Views & Analysis Deep Dive: Market Access It’s fair to say this is the most interesting time ever for market access.
News GSK gets second cancer drug approval from Nuvalent buy The FDA has cleared GSK's ALK inhibitor Nelkarmi for a form of lung cancer, the second product from its $10.6bn acquisition of Nuvalent.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.